Fibromyalgia Treatment Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AbbVie Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Aptinyx Inc.
- Tonix Pharmaceuticals Holding Corp.
- Virios Therapeutics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of fibromyalgia treatment is estimated at USD 3.31 billion.
The global fibromyalgia treatment market size exceeded USD 3.31 billion in 2026 and is set to expand at a CAGR of over 4.2%, surpassing USD 4.99 billion revenue by 2036.
The North America fibromyalgia treatment market will hold over 42.9% share by 2036, driven by increasing prevalence and rising awareness of fibromyalgia.
Key players in the market include Pfizer Inc., AbbVie Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Aptinyx Inc., Tonix Pharmaceuticals Holding Corp., Virios Therapeutics.
